Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Children and Adolescents with Tic Disorders or Tourette's
NCT00706589Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Oct 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in Tourette syndrome (TS), chronic tic disorder, sponsored by Otsuka Holdings. Started Oct 2008; status: completed.
02
Drugs
aripiprazole
03
Conditions
Tourette syndrome (TS)chronic tic disorder
Beyond the preview
Go deeper on NCT00706589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706589.